CardioPhi
Enhancing cardiac arrhythmia care and reducing cardiovascular disease costs with breakthrough solutions from a leading innovation hub.
Enhancing cardiac arrhythmia care and reducing cardiovascular disease costs with breakthrough solutions from a leading innovation hub.
CardioPhi is a health care startup dedicated to enhancing cardiac arrhythmia care and reducing cardiovascular disease costs through their breakthrough solutions. The company aims to improve outcomes for the millions of people affected by cardiac arrhythmias while also aiming to decrease public expenditure on cardiovascular diseases. CardioPhi is based out of the Harvard Innovation Labs and their latest investment, a $256.00K grant investment, was secured on 03 June 2022 from the National Science Foundation. This support from the National Science Foundation underscores the promising potential of CardioPhi's unique approach to addressing cardiac arrhythmias and could pave the way for further advancements in the field of cardiovascular health.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $256.00K | 1 |
|
03 Jun 2022 |
No recent news or press coverage available for CardioPhi.
We care about your data, and we'd love to use cookies make your experience better.
